Large-Scale Evaluation of Candidate Genes Identifies Associations between VEGF Polymorphisms and Bladder Cancer Risk
暂无分享,去创建一个
Nilanjan Chatterjee | Debra Silverman | Núria Malats | Nathaniel Rothman | Robert Welch | Stephen J Chanock | Montserrat García-Closas | Mustafa Dosemeci | Jonine Figueroa | Meredith Yeager | Adonina Tardón | Manolis Kogevinas | N. Malats | M. Kogevinas | A. Carrato | A. Tardón | D. Silverman | N. Rothman | S. Chanock | M. García-Closas | F. Real | N. Chatterjee | M. Yeager | R. Welch | R. Garcı́a-Closas | C. Serra | M. Dosemeci | J. Figueroa | C. Murta-Nascimento | Consol Serra | Alfredo Carrato | Reina García-Closas | Francisco X Real | Cristiane Murta-Nascimento
[1] D. Schaid. Evaluating associations of haplotypes with traits , 2004, Genetic epidemiology.
[2] L. Douglass,et al. expression and , 2006 .
[3] Wun-Jae Kim,et al. Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. , 2005, Urology.
[4] M. Bottomley,et al. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. , 2000, Cytokine.
[5] Sudhir Kumar,et al. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment , 2004, Briefings Bioinform..
[6] D. Ray,et al. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. , 2003, Cancer research.
[7] A. Harris,et al. Angiogenesis in bladder cancer--prognostic marker and target for future therapy. , 2002, Surgical oncology.
[8] K. Hemminki,et al. Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and Prognosis , 2005, Clinical Cancer Research.
[9] N. Malats,et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses , 2005, The Lancet.
[10] C. Carlson,et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. , 2004, American journal of human genetics.
[11] N. Laird,et al. Estimation and Tests of Haplotype-Environment Interaction when Linkage Phase Is Ambiguous , 2003, Human Heredity.
[12] Hugues Sicotte,et al. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes , 2005, Nucleic Acids Res..
[13] N. Saitou,et al. The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.
[14] W. Renner,et al. A Common 936 C/T Mutation in the Gene for Vascular Endothelial Growth Factor Is Associated with Vascular Endothelial Growth Factor Plasma Levels , 2000, Journal of Vascular Research.
[15] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[16] S. Chanock,et al. Vascular endothelial growth factor gene haplotypes in Kawasaki disease. , 2006, Arthritis and rheumatism.
[17] M. Kasuga,et al. Association of VEGF genotype with mRNA level in colorectal adenocarcinomas. , 2004, Biochemical and biophysical research communications.
[18] Nilanjan Chatterjee,et al. Exploiting Hardy-Weinberg Equilibrium for Efficient Screening of Single SNP Associations from Case-Control Studies , 2007, Human Heredity.
[19] H. Ozen. Bladder cancer. , 1998, Current opinion in oncology.
[20] P. Harden,et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. , 2002, Journal of the American Society of Nephrology : JASN.